Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $402.98 -0.01%
Revenue Growth %: +5.1%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
VFS, PKE, More
Revenue Growth %: +5.1%
Financial Fact:
Interest expense, net: 325M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q1 EPS of $5.15, $0.35 better than the analyst estimate of $4.80. Revenue for the quarter came in at $8.62 billion versus the consensus estimate of $8.59 billion.
GUIDANCE:
Amgen sees FY2026 EPS of $21.70-$23.10, versus the consensus of $22.30. Amgen sees FY2026 revenue of $37.1-38.5 billion, versus the consensus of $37.79 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- Lucid Group reports Q3 2026 production and delivery figures
- Freshworks to join S&P SmallCap 600 index
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
